212
Participants
Start Date
March 31, 2013
Primary Completion Date
December 14, 2021
Study Completion Date
December 14, 2022
CTLA4-Ig (Abatacept)
Given as 30 minute IV infusion
Placebo
Saline given as 30 minute IV infusion
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
University of Pittsburgh, Pittsburgh
University of Miami School of Medicine, Miami
Indiana University-Riley Hospital for Children, Indianapolis
University of Minnesota, Minneapolis
University of Chicago, Chicago
Baylor College of Medicine, Houston
Barbara Davis Center for Childhood Diabetes, University of Colorado, Denver
University of California - San Francisco, San Francisco
Benaroya Research Institute at Virginia Mason, Seattle
Stanford University Medical Center, Stanford
Yale Medical School, New Haven
Columbia University, New York
Vanderbilt University, Nashville
University of Florida, Gainesville
University of Texas Medical Center at Dallas, Dallas
The Hospital for Sick Children, Toronto
Collaborators (1)
Juvenile Diabetes Research Foundation
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH